Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy
Abstract
Spinal muscular atrophy (SMA) is a motoneuron disease caused by reduced levels of survival motoneuron (SMN) protein. Previous studies have assigned SMN to uridine-rich small nuclear ribonucleoprotein particle (U snRNP) assembly, splicing, transcription, and RNA localization. Here, we have used gene silencing to assess the effect of SMN protein deficiency on U snRNP metabolism in living cells and organisms. In HeLa cells, we show that reduction of SMN to levels found in SMA patients impairs U snRNP assembly. In line with this, induced silencing of SMN expression in Xenopus laevis or zebrafish arrested embryonic development. Under less severe knock-down conditions, zebrafish embryos proceeded through development yet exhibited dramatic SMA-like motor axon degeneration. The same was observed after silencing two other essential factors in the U snRNP assembly pathway, Gemin2 and pICln. Importantly, the injection of purified U snRNPs into either SMN- or Gemin2-deficient embryos of Xenopus and zebrafish prevented developmental arrest and motoneuron degeneration, respectively. These findings suggest that motoneuron degeneration in SMA patients is a direct consequence of impaired production of U snRNPs.
Keywords
Footnotes
-
Supplemental material is available at http://www.genesdev.org.
-
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.342005.
-
↵5 These authors contributed equally to this work.
-
↵6 Corresponding author.
↵6 E-MAIL utz.fischer{at}biozentrum.uni-wuerzburg.de; FAX 49-931-888-4028.
-
- Accepted July 27, 2005.
- Received March 1, 2005.
- Cold Spring Harbor Laboratory Press